Trade Filings
Managers Aandelen Ingediende stukken Superinvesteerders
Signalen Institutionele aankopen Institutionele verkopen Insider-activiteit 13D & 13G Watch Sectorrotatie
Tools Aandelenscreener Manager Screener Beheerders vergelijken Consensusmandjes Alle onderzoekstools Data-API
Leren & AI Leren Vraag de data AI-agents
Nieuws ★ Opgeslagen
Over Over ons Methodologie Contact Disclaimer
Reader
DATAPAKKETTEN

Downloads van historische gegevens — beschikbaar met accounts.

API GATEWAY

Gratis alleen-lezen JSON-toegang tot de gecachede gegevens van de site.

Donkere modus

🧭 Begeleide weergave
Nieuw met markten — koersen, yields, YTD, marktkapitalisatie? We leggen elk begrip uit terwijl u bladert, in begrijpelijke taal. Dezelfde data, met ingebouwde uitleg.

⚡ Expertvisie
U kent de markt al. Alleen de data — schoon, snel en compact, zonder extra uitleg. Dit is de standaardweergave.

Interfacetaal
Effectdossier · gearchiveerd kwartaal

XENE

Xenon Pharmaceuticals Inc. · Healthcare · Biotechnology

60.16 -0.4% marktkapitalisatie $5.82B koers vertraagd (FMP) · per Aug 26 14:08 UTC — los van onderstaande aangiftegegevens

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
114Gevolgde houders
+7Δ houders
55.64MGehouden aandelen
$3.35BGerapporteerde waarde
+11Nieuwe posities
−4Uitstappen
Rising Overtuigingsscore 44/100 Hoe deze worden berekend → Dit toelichten aan de Research Desk →

Momentum-inputs (vergelijkbare managers): breedte van houders +6.5% · aandelenstroom +1.4% · netto nieuwe posities +6.1%formule
Brede accumulatie — stijgende aandelen bij meer houders

Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2026

Eigendom in de tijd
KwartaalHoudersΔAandelenGerapporteerde waardeNieuwUitstappen
Q2 2026 114 +7 55.64M $3.35B +11 −4
Q1 2026 110 +12 59.13M $3.41B +18 −6
Q4 2025 96 0 51.65M $2.31B +1 −1
Q3 2025 17 0 29.02M $1.17B
Q2 2025 14 -1 23.81M $745.12M +1 −2
Q1 2025 12 +1 10.74M $360.22M +1
Q4 2024 11 -1 10.24M $401.45M −1
Q3 2024 11 0 11.68M $459.86M
Q2 2024 11 11.68M $455.36M
Aantal houders
Wie het bezit · Q2 2026
#ManagerAandelenΔ aandelenWaardeHun gewichtGehouden
1 Fidelity (FMR) 9.65M -10.8% $582.35M 0.0% ▼ Trim 5 SEC ↗
2 Fidelity (FMR) 9.65M -10.8% $582.35M 0.0% ▼ Trim 5 SEC ↗
3 Fidelity (FMR) 9.65M -10.8% $582.35M 0.0% ▼ Trim 5 SEC ↗
4 Fidelity (FMR) 9.65M -10.8% $582.35M 0.0% ▼ Trim 5 SEC ↗
5 Fidelity (FMR) 9.65M -10.8% $582.35M 0.0% ▼ Trim 5 SEC ↗
6 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
7 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
8 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
9 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
10 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
11 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
12 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
13 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
14 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
15 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
16 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
17 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
18 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
19 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
20 BlackRock (passief) 7.52M +33.4% $454.06M 0.0% ▲ Add 5 SEC ↗
21 T. Rowe Price 3.25M +144.3% $196.06M 0.0% ▲ Add 5 SEC ↗
22 T. Rowe Price 3.25M +144.3% $196.06M 0.0% ▲ Add 5 SEC ↗
23 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
24 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
25 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
26 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
27 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
28 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
29 JPMorgan Chase 2.62M +36.1% $157.38M 0.0% ▲ Add 4 SEC ↗
30 Capital International Investors 2.36M -11.7% $142.55M 0.0% ▼ Trim 3 SEC ↗
31 State Street Global Advisors (passief) 1.97M +14.5% $118.89M 0.0% ▲ Add 7 SEC ↗
32 Two Sigma Investments 1.64M +171.1% $99.16M 0.1% ▲ Add 3 SEC ↗
33 Alliancebernstein L.P. 1.56M +11.3% $90.85M 0.0% ▲ Add 3 SEC ↗
34 Franklin Resources Inc 1.44M +12.3% $86.78M 0.0% ▲ Add 3 SEC ↗
35 Franklin Resources Inc 1.44M +12.3% $86.78M 0.0% ▲ Add 3 SEC ↗
36 Franklin Resources Inc 1.44M +12.3% $86.78M 0.0% ▲ Add 3 SEC ↗
37 Franklin Resources Inc 1.44M +12.3% $86.78M 0.0% ▲ Add 3 SEC ↗
38 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
39 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
40 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
41 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
42 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
43 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
44 Wellington Management 1.43M -70.5% $86.04M 0.0% ▼ Trim 9 SEC ↗
45 Citadel Advisors 1.40M -47.2% $84.58M 0.0% ▼ Trim 9 SEC ↗
46 Citadel Advisors 1.40M -47.2% $84.58M 0.0% ▼ Trim 9 SEC ↗
47 Geode Capital Management (passief) 1.37M +25.4% $82.69M 0.0% ▲ Add 9 SEC ↗
48 Geode Capital Management (passief) 1.37M +25.4% $82.69M 0.0% ▲ Add 9 SEC ↗
49 BNP Paribas Asset Management… 1.29M -3.8% $77.91M 0.1% ▼ Trim 3 SEC ↗
50 BNP Paribas Asset Management… 1.29M -3.8% $77.91M 0.1% ▼ Trim 3 SEC ↗
51 BNP Paribas Asset Management… 1.29M -3.8% $77.91M 0.1% ▼ Trim 3 SEC ↗
52 Pictet Asset Management Holding SA 1.19M +74.7% $71.65M 0.1% ▲ Add 3 SEC ↗
53 Nuveen, LLC 993.13K +297.2% $59.95M 0.0% ▲ Add 3 SEC ↗
54 Nuveen, LLC 993.13K +297.2% $59.95M 0.0% ▲ Add 3 SEC ↗
55 Nuveen, LLC 993.13K +297.2% $59.95M 0.0% ▲ Add 3 SEC ↗
56 Invesco Ltd. 903.46K +1428.6% $54.53M 0.0% ▲ Add 3 SEC ↗
57 Invesco Ltd. 903.46K +1428.6% $54.53M 0.0% ▲ Add 3 SEC ↗
58 Invesco Ltd. 903.46K +1428.6% $54.53M 0.0% ▲ Add 3 SEC ↗
59 Invesco Ltd. 903.46K +1428.6% $54.53M 0.0% ▲ Add 3 SEC ↗
60 Invesco Ltd. 903.46K +1428.6% $54.53M 0.0% ▲ Add 3 SEC ↗
61 Invesco Ltd. 903.46K +1428.6% $54.53M 0.0% ▲ Add 3 SEC ↗
62 American Century Companies Inc 884.32K +30.2% $53.38M 0.0% ▲ Add 3 SEC ↗
63 Federated Hermes, Inc. 883.74K -9.1% $53.34M 0.1% ▼ Trim 3 SEC ↗
64 Capital World Investors 862.77K +2.7% $52.08M 0.0% ▲ Add 9 SEC ↗
65 Goldman Sachs Group 773.62K +0.5% $46.70M 0.0% ▲ Add 4 SEC ↗
66 Goldman Sachs Group 773.62K +0.5% $46.70M 0.0% ▲ Add 4 SEC ↗
67 Goldman Sachs Group 773.62K +0.5% $46.70M 0.0% ▲ Add 4 SEC ↗
68 Goldman Sachs Group 773.62K +0.5% $46.70M 0.0% ▲ Add 4 SEC ↗
69 Alyeska Investment Group, L.P. 697.69K -46.3% $42.11M 0.1% ▼ Trim 2 SEC ↗
70 Marshall Wace 689.34K Nieuw $41.61M 0.0% New 1 SEC ↗
71 Marshall Wace 689.34K Nieuw $41.61M 0.0% New 1 SEC ↗
72 Northern Trust Corp 671.57K +27.2% $40.54M 0.0% ▲ Add 3 SEC ↗
73 Northern Trust Corp 671.57K +27.2% $40.54M 0.0% ▲ Add 3 SEC ↗
74 Northern Trust Corp 671.57K +27.2% $40.54M 0.0% ▲ Add 3 SEC ↗
75 Northern Trust Corp 671.57K +27.2% $40.54M 0.0% ▲ Add 3 SEC ↗
76 Northern Trust Corp 671.57K +27.2% $40.54M 0.0% ▲ Add 3 SEC ↗
77 Tudor Investment Corp Et Al 545.39K +10.1% $32.92M 0.1% ▲ Add 3 SEC ↗
78 Loomis Sayles & Co L P 527.27K -6.7% $31.83M 0.0% ▼ Trim 3 SEC ↗
79 Loomis Sayles & Co L P 527.27K -6.7% $31.83M 0.0% ▼ Trim 3 SEC ↗
80 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
81 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
82 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
83 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
84 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
85 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
86 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
87 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
88 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
89 Bank of New York Mellon Corp 421.52K +6.4% $25.44M 0.0% ▲ Add 3 SEC ↗
90 Aberdeen Group plc 408.74K -33.0% $24.67M 0.0% ▼ Trim 3 SEC ↗
91 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
92 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
93 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
94 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
95 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
96 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
97 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
98 Morgan Stanley 406.26K -14.2% $24.52M 0.0% ▼ Trim 4 SEC ↗
99 Bank Of America Corp /De/ 404.07K +52.3% $24.39M 0.0% ▲ Add 3 SEC ↗
100 Bank Of America Corp /De/ 404.07K +52.3% $24.39M 0.0% ▲ Add 3 SEC ↗

"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.

Nieuwe kopers

Marshall Wace $41.61M 0.0%
Marshall Wace $41.61M 0.0%

Verlaten

Holocene Advisors, LP $88.31M was 0.2%
LMR Partners LLP $3.27M was 0.0%
Qube Research & Technologies… $2.56M was 0.0%
Jane Street Group, Llc $201,664 was 0.0%

Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 129.80K aandelen, $7,547 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.

Vaak gezamenlijk in bezit

Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.

Insider-transacties

Open-market aankopen (P)

Geen open-market insider-aankopen in ons dekkingsvenster.

Open-market verkopen (S)

Aug 11 GANNON STEVEN

Director · 10.00K aand · $640,550

Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie

Beneficial ownership
Aug 13 SC 13G/A — WELLINGTON MANAGEMENT GROUP LLP

Originele SEC-indiening bekijken ↗

Aug 07 SC 13G/A — FMR LLC

Originele SEC-indiening bekijken ↗

Aug 06 SC 13G/A — FMR LLC

Originele SEC-indiening bekijken ↗

Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR. Rapportageperiode: Q2 2026 · Methodologie · Verkrijg dit via de API